|
US2020188316A1
|
|
Transdermal formulations suitable for administration of natural products comprising plant flour and an adhesive
|
|
US2013303860A1
|
|
Systems and methods for use in fall risk assessment
|
|
US2013281888A1
|
|
Task-associated motion analysis
|
|
US2013245078A1
|
|
Salt compound
|
|
US2010221247A1
|
|
Agents and methods for treatment of cancer
|
|
US2009016956A1
|
|
Labeled Macrophages and Methods of Use Thereof
|
|
WO2008096203A2
|
|
Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders
|
|
WO2007119103A1
|
|
Labeled macrophages and methods of use thereof
|
|
WO2007074406A2
|
|
Formulations for treatment of lipoprotein abnormalities comprising a statin a statin and a methylnicotinamide derivative
|
|
US2006286151A1
|
|
Production of foie gras
|
|
CA2434101A1
|
|
Direct participation business model
|
|
US4560390A
|
|
Method of beneficiating coal
|
|
US4328002A
|
|
Methods of treating coal to remove sulfur and ash
|
|
US4211163A
|
|
Apparatus for discharge of pressure cooked particulate or fibrous material
|
